Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
Ontario Brain Institute, EpiSign Partner on Rare Genetic Disorder Diagnosis
OBI's Center for Analytics and EpiSign will refine and validate EpiSign's machine-learning algorithm that analyzes a person's epigenome to detect rare genetic disorders.
Precision Oncology Investments Continue Amid Stubborn Operational Difficulties, Survey Shows
Premium
Precision Medicine Online's 2024 survey shows biomarker test expansion but low clinical trial enrollment and long wait times for advanced therapies.
Labor Dr. Wisplinghoff, Genomic Testing Cooperative Partner to Offer Cancer Testing in Germany
Labor Dr. Wisplinghoff will offer GTC's next-generation sequencing-based tests for solid tumor and hematologic neoplasms.
A discussion at the Precision Medicine Tri-Con demonstrated that stakeholders are narrowing in on the challenges to realizing the promise of solid tumor MRD.
In Brief This Week: Count Me In, TeleRare Health, VolitionRx, Ascentage, Atsena, ClearNote Health
News items for the week of March 10, 2025.
Jan 27, 2025